docetaxel anhydrous has been researched along with pevonedistat in 2 studies
| Studies (docetaxel anhydrous) | Trials (docetaxel anhydrous) | Recent Studies (post-2010) (docetaxel anhydrous) | Studies (pevonedistat) | Trials (pevonedistat) | Recent Studies (post-2010) (pevonedistat) |
|---|---|---|---|---|---|
| 12,110 | 3,216 | 6,920 | 299 | 11 | 289 |
| Protein | Taxonomy | docetaxel anhydrous (IC50) | pevonedistat (IC50) |
|---|---|---|---|
| Ubiquitin-like modifier-activating enzyme 6 | Homo sapiens (human) | 1.8 | |
| Ubiquitin-like modifier-activating enzyme 1 | Mus musculus (house mouse) | 1.5 | |
| NEDD8-activating enzyme E1 regulatory subunit | Homo sapiens (human) | 0.0471 | |
| NEDD8 | Homo sapiens (human) | 0.0047 | |
| NEDD8-activating enzyme E1 catalytic subunit | Homo sapiens (human) | 0.0033 | |
| SUMO-activating enzyme subunit 1 | Homo sapiens (human) | 8.2 | |
| SUMO-activating enzyme subunit 2 | Homo sapiens (human) | 8.2 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bauer, TM; Faessel, H; Faller, DV; Harvey, RD; Lockhart, AC; Nemunaitis, J; Sedarati, F; Venkatakrishnan, K; Zhou, X | 1 |
| Bouchal, J; Gachechiladze, M; Kharaishvili, G; Kral, M; Kurfurstova, D; Mickova, A; Mistrik, M; Pokryvkova, B; Soucek, K; Vacek, O | 1 |
1 trial(s) available for docetaxel anhydrous and pevonedistat
| Article | Year |
|---|---|
Effect of CYP3A inhibitors on the pharmacokinetics of pevonedistat in patients with advanced solid tumours.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Carboplatin; Cyclopentanes; Cytochrome P-450 CYP3A Inhibitors; Docetaxel; Drug Interactions; Enzyme Inhibitors; Female; Fluconazole; Humans; Itraconazole; Male; Middle Aged; Neoplasms; Paclitaxel; Pyrimidines | 2019 |
1 other study(ies) available for docetaxel anhydrous and pevonedistat
| Article | Year |
|---|---|
Skp2 and Slug Are Coexpressed in Aggressive Prostate Cancer and Inhibited by Neddylation Blockade.
Topics: Antigens, CD; Antineoplastic Agents; Cadherins; Cell Line, Tumor; Cell Survival; Cyclin-Dependent Kinase Inhibitor p27; Cyclopentanes; Docetaxel; Epithelial-Mesenchymal Transition; Gene Expression Regulation, Neoplastic; Humans; Lymphatic Metastasis; Male; NEDD8 Protein; Neoplasm Grading; PC-3 Cells; Prostate; Prostatic Neoplasms; Protein Processing, Post-Translational; Pyrimidines; Receptors, Androgen; RNA, Small Interfering; S-Phase Kinase-Associated Proteins; Snail Family Transcription Factors | 2021 |